(Q38289423)

English

Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial

scientific article

Statements

Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial (English)
Meike H van der Ree
J Marleen de Vree
Femke Stelma
Sophie Willemse
Marc van der Valk
Svend Rietdijk
Ad C van Nuenen
Ulrich Beuers
Salah Hadi
Marten Harbers
Eva van der Veer
Kai Liu
John Grundy
Amy K Patick
Adam Pavlicek
Jacqueline Blem
Michael Huang
Paul Grint
Steven Neben
Neil W Gibson
Hendrik W Reesink
10 January 2017
10070
709-717

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit